Heart failure and atrial fibrillation in patients with an interatrial shunt

Jin Joo Park1, Goo-Yeong Cho2, Wonsuk Choi1

  • 1Department of Internal Medicine, Cardiovascular Center, Seoul National University College of Medicine, Seoul National University Bundang Hospital, 82, Gumi-Ro 173, Bundang-Gu, Seongnam-Si, 13620, Gyeonggi-do, Republic of Korea.

Insights

Patients with congenital interatrial shunts have a lower risk of developing heart failure (HF) or atrial fibrillation (AF). These shunts may be beneficial, reducing the need for closure in carefully selected stroke or TIA patients.

Area of Science:

  • Cardiology
  • Neurology
  • Medical Imaging

Background:

  • Congenital interatrial shunts can decompress the left atrium (LA).
  • This decompression may potentially reduce the incidence of new-onset heart failure (HF) and atrial fibrillation (AF).

Purpose of the Study:

  • To evaluate the risk of new-onset HF or AF in patients with and without an interatrial shunt.
  • To determine the association between interatrial shunts and cardiovascular outcomes in patients with acute stroke or transient ischemic attack (TIA).

Main Methods:

  • A cohort of 2660 patients with acute stroke or TIA was analyzed.
  • Transesophageal echocardiography was used to identify interatrial shunts.
  • The 10-year incidence of new-onset HF, AF, and a composite of HF or AF was assessed.

Main Results:

  • 17.5% of patients had an interatrial shunt, exhibiting smaller E velocity and E/e' ratios.
  • The 10-year incidence of AF, HF, and the composite outcome was significantly lower in patients with interatrial shunts.
  • Multivariable analysis revealed that interatrial shunts were associated with a reduced risk of new-onset HF (38%), AF (40%), and the composite outcome (26%).

Conclusions:

  • The presence of an interatrial shunt is associated with a lower risk of new-onset AF and HF.
  • Interatrial shunts may confer cardiovascular benefits, suggesting closure should be reserved for carefully selected patients.
  • In patients presenting with stroke or TIA, interatrial shunts are linked to a decreased risk of subsequent HF and AF.
Abstract

Related Concept Videos

Heart Failure VI: Adjunct Therapies01:22

Heart Failure VI: Adjunct Therapies

Additional therapies for treating patients with heart failure (HF) may include procedural interventions, supplemental oxygen, the management of sleep disorders, and nutritional therapy.Procedural InterventionsImplantable Cardioverter-Defibrillator: For patients at risk of life-threatening arrhythmias due to severe left ventricular dysfunction, an Implantable Cardioverter-Defibrillator (ICD) can detect and terminate these arrhythmias, preventing sudden cardiac death and improving survival rates.
101
Imbalances in Cardiac Output01:26

Imbalances in Cardiac Output

The heart's primary function is to pump blood throughout the body, maintaining a balance between blood sent out (cardiac output) and blood returning (venous return). If this balance is disrupted, it can result in congestive heart failure (CHF), a severe condition where the heart becomes an inefficient pump, leading to inadequate blood circulation.
CHF can occur due to the failure of either side of the heart. Left-side failure leads to pulmonary congestion—the right side continues to send...
1.9K
Heart Failure I: Introduction01:27

Heart Failure I: Introduction

Heart failure refers to a clinical syndrome caused by structural or functional cardiac disorders that prevent the heart from pumping an adequate amount of blood to meet the body's metabolic needs. This condition often arises from myocardial infarction or ischemia, leading to decreased cardiac output, reduced tissue perfusion, impaired gas exchange, fluid volume imbalance, and decreased functional ability.Heart failure can result from disruptions in the mechanisms that regulate cardiac output...
241
Mitral Regurgitation I: Introduction01:20

Mitral Regurgitation I: Introduction

Mitral regurgitation is characterized by the backward circulation of blood from the left ventricle to the left atrium during systole, a phase of the cardiac cycle when the heart contracts and pumps blood out of the chambers. This abnormal flow occurs primarily due to the dysfunction of the mitral valve or its supporting structures, which include the mitral leaflets, chordae tendineae, annulus, and papillary muscles.Etiology and Mechanisms:Primary Mitral Regurgitation: This type arises from...
168
Mitral Stenosis I: Introduction01:22

Mitral Stenosis I: Introduction

Mitral Valve Stenosis (MVS) is a heart condition where the mitral valve narrows, impeding blood circulation from the left atrium to the left ventricle. The etiology and pathophysiology of this condition are multifaceted, leading to a cascade of cardiovascular complications.Causes of Mitral Valve StenosisRheumatic Heart Disease: It is the main cause of mitral valve stenosis, particularly in developing nations. This condition arises from rheumatic fever, an inflammatory illness resulting from...
142
Cardiomyopathy III: Hypertrophic Cardiomyopathy01:29

Cardiomyopathy III: Hypertrophic Cardiomyopathy

Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...
144